Evidence Hub

Vaping: A Safe Alternative to Counteract Smoking? Case Report

M. C. Martínez-Ávila, Eugenio Matijasevic Ardila, Alieth Lucía Acosta Cardozo, Cristian Camilo Alvarado Castro, C. E. Matiz-Bueno

Clinical Medicine Insights: Case Reports, 2025

1 citation

Abstract

The respiratory impact of e-cigarette usage, also known as vaping, emerged as a significant healthcare issue in 2019. This concern arose due to the sharp rise in cases of e-cigarette or vaping-associated lung injury (EVALI) among adolescents and young adults. Now, systemic manifestations have been described. We present the case of a 39-year-old male patient who had been vaping for 5 years and developed EVALI associated with multiple severe complications, including acute myocardial infarction, metabolic acidosis, acute kidney injury and sepsis-like syndrome, requiring hospitalization in the critical care unit. Every day, reports of patients with systemic complications due to the use of e-cigarettes are becoming more frequent. Therefore, it is crucial for clinicians to be aware of this condition and to consider whether vaping truly constitutes a safe alternative to combat smoking.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free